ANDA 79054, held by Torrent Pharmaceuticals. Alfuzosin Hydrochloride.
As of Nov 22, 2026, ANDA 79054 (Alfuzosin Hydrochloride), held by Torrent Pharmaceuticals, was first approved by FDA on Jul 18, 2011, with 7 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jul 18, 2011 | Original application | Approved |
| Product | Active ingredient | Marketing |
|---|---|---|
| Alfuzosin Hydrochloride10MG ยท tablet, extended release;oral | Alfuzosin Hydrochloride | Discontinued |
| Sep 15, 2022 | Supplement 17Labeling ยท Standard review | Approved | None posted |
| Dec 7, 2018 | Supplement 15Labeling ยท Standard review | Approved | None posted |
| Jan 15, 2015 | Supplement 6Labeling ยท Standard review | Approved | None posted |
| Jan 15, 2015 | Supplement 8Labeling ยท Standard review | Approved | None posted |
| Jan 15, 2015 | Supplement 10Labeling ยท Standard review | Approved | None posted |
| Nov 18, 2014 | Supplement 4Manufacturing | Approved | None posted |
| Jul 11, 2013 | Supplement 3Labeling | Approved | None posted |
| Jul 18, 2011 | Original application | Approved |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. โWhat FDA's review saysโ is read by a model (Claude Haiku) from FDA's summary review PDF; a field is shown only if its numbers appear in the review, and each section links the review. Drugs@FDA and FDA complete response letters